InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

- Current share price for NOX : $0.078

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 Cleansing Statement 3 Dec 2020 9:34AM $0.640 $0.078 fallen by 87.81%
$24 Proposed issue of Securities - NOX 3 Dec 2020 9:30AM $0.640 $0.078 fallen by 87.81%
$24 Noxopharm Completes A$23m Placement to Fund Clinical Studies 3 Dec 2020 9:30AM $0.640 $0.078 fallen by 87.81%
$24 Appendix 2A 1 Dec 2020 1:35PM $0.640 $0.078 fallen by 87.81%
$24 Trading Halt 1 Dec 2020 9:08AM $0.640 $0.078 fallen by 87.81%
$24 Change of Director's Interest Notice - PM 27 Nov 2020 6:38PM $0.635 $0.078 fallen by 87.72%
$24 Lapsing of Unlisted Options 27 Nov 2020 4:34PM $0.635 $0.078 fallen by 87.72%
$24 Change of Director's Interest Notice - GK 18 Nov 2020 12:42PM $0.710 $0.078 fallen by 89.01%
$24 Cleansing Notice 18 Nov 2020 12:38PM $0.710 $0.078 fallen by 89.01%
$24 Appendix 2A 18 Nov 2020 12:37PM $0.710 $0.078 fallen by 89.01%
$24 Appendix 3G 18 Nov 2020 12:33PM $0.710 $0.078 fallen by 89.01%
$24 Further Independent Support for Veyonda as a Major I-O Drug 18 Nov 2020 9:23AM $0.675 $0.078 fallen by 88.44%
$24 Noxopharm Annual General Meeting Results 17 Nov 2020 4:06PM $0.675 $0.078 fallen by 88.44%
$24 Noxopharm 2020 AGM Corporate Update 17 Nov 2020 9:53AM $0.635 $0.078 fallen by 87.72%
$24 2020 AGM Chairman's Address 17 Nov 2020 8:42AM $0.635 $0.078 fallen by 87.72%
$24 Independent Discovery Validates DARRT Cancer Therapy 13 Nov 2020 8:38AM $0.565 $0.078 fallen by 86.19%
$24 Veyonda To Be Tested In Combination With Opdivo In Trial 9 Nov 2020 10:21AM $0.530 $0.078 fallen by 85.28%
$24 Dedicated Septic Shock Company Established 5 Nov 2020 11:03AM $0.510 $0.078 fallen by 84.71%
$24 NOXCOVID Study Cleared To Expand 5 Nov 2020 10:58AM $0.490 $0.078 fallen by 84.08%
$24 2020 Annual General Meeting Reminder 3 Nov 2020 8:23AM $0.465 $0.078 fallen by 83.23%
$24 Cleansing Notice 26 Oct 2020 1:01PM $0.515 $0.078 fallen by 84.85%
$24 Appendix 2A 26 Oct 2020 12:57PM $0.505 $0.078 fallen by 84.55%
$24 First Two Cohorts Enrolled in NOXCOVID Study 26 Oct 2020 9:33AM $0.505 $0.078 fallen by 84.55%
$24 Noxopharm Quarterly Activities Report & Appendix 4C 15 Oct 2020 8:24AM $0.415 $0.078 fallen by 81.20%
$24 Cover Letter and Proxy Form - Annual General Meeting 14 Oct 2020 8:23AM $0.415 $0.078 fallen by 81.20%

326 - 350 of 794 results

Page 14 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.